Title
Serdar Balcı
Serdar BALCI, MD
DRUG- OR TOXIN-INDUCED LIVER DISEASE
Drug- or Toxin-Induced Liver Disease
- Liver is the major detoxifying organ
- Injury may result from;
- Direct toxicity
- Hepatic conversion of a xenobiotic to an active toxin
- By immune mechanisms
- a drug or a metabolite acting as a hapten to convert a cellular
protein into an immunogen
- Diagnosis depends on
- Association of agent and liver injury in terms of time
- Recovery on removal of the compound
- Exclusion of other causes
- Should be in differential diagnosis list always
- Most important agent that produces toxic liver injury is alcohol
Drug-induced liver disease
- Common condition
- May manifest as
- A mild reaction
- Acute liver failure
- Chronic liver disease
- Caused by:
- Drugs or medicines
- Herbal remedies
- Dietary supplements
- Topical applications (e.g., ointments, perfumes, shampoo)
- Environmental exposures (e.g., cleaning solvents, pesticides,
fertilizers)
Robbins Basic Pathology
Drug reactions
- Predictable
- Unpredictable (idiosyncratic)
- Individual host variations
- Immune response to drug-related antigen
- The rate at which the agent is metabolized
- Both classes of injury may be immediate or take weeks to months to
develop
Many drugs cause hepatic injury
**For updated information **
Predictable
- Acetaminophen
- Most common cause of acute liver failure necessitating
transplantation in the United States
- Intentional suicidal overdoses are common, so are accidental
overdoses
- Codeine, alcohol upregulate P-450 system → acetaminophen is more
toxic
- The toxic agent is not acetaminophen itself but toxic metabolites
produced by the cytochrome P-450 system in acinus zone 3 hepatocytes
- These cells die, the zone 2 hepatocytes take over this metabolic
function, in turn
- In severe overdoses the zone of injury extends to the periportal
hepatocytes, resulting in fulminant hepatic failure
Idiosyncratic
- Chlorpromazine
- causes cholestasis in individuals who metabolize it slowly
- Halothane
- fatal immune-mediated hepatitis
- Sulfonamides
- α-methyldopa
- Idiosyncratic drug or toxin reactions involve a variable combination
of
- Direct cytotoxicity
- Immune-mediated hepatocyte or bile duct destruction
Depending on the toxic material different zones may be affected
If the toxin is a metabolite of a drug then it may accumulate in zone
3 and most severe effect is seen in zone 3
Robbins Basic Pathology
Robbins Basic Pathology
**Acetaminophen overdose. Confluent necrosis is seen in the perivenular
region (zone 3) **
Robbins Basic Pathology
ALCOHOLIC AND NONALCOHOLIC FATTY LIVER DISEASE
Fatty Liver Disease
- Alcohol
- Steatosis
- Steatohepatitis
- Cirrhosis
- Nonalcoholic fatty liver disease (NAFLD)
- Similar hepatic changes with alcohol
- Associated with metabolic syndrome
- insulin resistance, obesity, diabetes mellitus, hypertension,
and dyslipidemia
Hepatocellular Steatosis
- Fat accumulation typically begins in centrilobular hepatocytes
- Small (microvesicular), large (macrovesicular)
- Later midlobule and then the periportal regions
- Macroscopically, the fatty liver with widespread steatosis
- Large (weighing 4 to 6 kg or more), soft, yellow, and greasy
Fatty liver disease. Macrovesicular steatosis is most prominent around
the central vein and extends outward to the portal tracts with
increasing severity. The intracytoplasmic fat is seen as clear vacuoles.
Some fibrosis (stained blue) is present in a characteristic
perisinusoidal “chicken wire fence” pattern.
Robbins Basic Pathology
Steatohepatitis
More with alcohol use than in NAFLD
Hepatocyte ballooning
Mallory-Denk bodies
Neutrophilic reaction
- Hepatocyte ballooning
- Single or scattered foci of cells undergo swelling and necrosis
- Start from centrilobular areas
- Mallory-Denk bodies
- tangled intermediate filaments
- eosinophilic cytoplasmic inclusions in degenerating hepatocytes
clustered inflammatory cells
necrotic hepatocyte
**Mallory-Denk body **
Robbins Basic Pathology
**keratins 8 and 18 **
**ballooned hepatocytes **
Robbins Basic Pathology
Neutrophil infiltration
Predominantly neutrophilic infiltration may permeate the lobule
Accumulate around degenerating hepatocytes, particularly those
containing Mallory-Denk bodies
Lymphocytes and macrophages also may be seen in portal tracts or
parenchyma
Steatohepatitis with fibrosis
First in the centrilobular region, central vein sclerosis
Perisinusoidal scar appears in the space of Disse of the centrilobular
region
Spreads outward, encircling individual or small clusters of
hepatocytes in a chicken wire fence pattern
Link to portal tracts
Condense to create central-portal fibrous septa
Liver takes on a nodular, cirrhotic appearance
Classic micronodular or Laennec cirrhosis
Course of Fatty Liver Disease
- Early
- the liver is yellow-tan, fatty, and enlarged
- Later
- Persistent damage
- **Brown, shrunken, nonfatty organ composed of cirrhotic nodules that
are usually less than 0.3 cm in diameter, smaller than is typical
for most chronic viral hepatitis **
- End-stage cirrhotic liver may enter into a “burned-out” phase
- No fatty change and other typical features
Steatosis or fatty change imparts a yellow to orange cast to the liver
parenchyma
Autopsy Pathology: A Manual and Atlas
Alcoholic cirrhosis
Diffuse nodularity. Average nodule size is 3 mm. Greenish because of
bile stasis
Robbins Basic Pathology
Steatohepatitis leading to cirrhosis. Small nodules are entrapped in
blue-staining fibrous tissue; fatty accumulation is no longer seen in
this “burned-out” stage
Robbins Basic Pathology
Alcoholic liver disease
Steatosis, alcoholic hepatitis, and fibrosis may develop
independently
Not necessarily represent a continuum of changes
Hepatocellular carcinoma arises in 10-20% of patients with alcoholic
cirrhosis
Alcoholic liver disease
Robbins Basic Pathology
Causes of hepatocellular steatosis
- Shunting of substrates away from catabolism and toward lipid
biosynthesis
- Generation of excess reduced nicotinamide-adenine dinucleotide
- metabolism of ethanol by alcohol dehydrogenase and acetaldehyde
dehydrogenase
- Impaired assembly and secretion of lipoproteins
- Increased peripheral catabolism of fat
Causes of alcoholic hepatitis
- Acetaldehyde
- metabolite of ethanol
- induces lipid peroxidation and acetaldehyde-protein adduct
formation
- disrupt cytoskeleton and membrane function
- Alcohol directly affects
- cytoskeleton
- mitochondrial function
- membrane fluidity
- Reactive oxygen species
- oxidation of ethanol by the microsomal ethanol oxidizing system
- neutrophils, areas of hepatocyte necrosis
- Cytokine-mediated inflammation and cell injury
- Generation of acetaldehyde and free radicals is maximal in the
centrilobular region, this region is most susceptible to toxic injury.
Pericellular fibrosis and sinusoidal fibrosis develop in this area of
the lobule.
- Concurrent viral hepatitis, hepatitis C, is a major accelerator of
liver disease in alcoholics
Nonalcoholic Fatty Liver Disease (NAFLD)
- Metabolic syndrome
- Having at least two of the following:
- Obesity, insulin resistance, dyslipidemia, and hypertension
- Insulin resistance results in the accumulation of triglycerides in
hepatocytes
- Impaired oxidation of fatty acids
- Increased synthesis and uptake of fatty acids
- Decreased hepatic secretion of very-low-density lipoprotein
cholesterol
- Fat-laden hepatocytes
- highly sensitive to lipid peroxidation products generated by
oxidative stress
- damage mitochondrial and plasma membranes, causing apoptosis
- Most common cause of incidental elevation of serum transaminases
- Significant contributor to the pathogenesis of “cryptogenic”
cirrhosis
- Pediatric NAFLD
- Increasing problem as metabolic syndrome and NAFLD approach
epidemic proportions
- In children
- Inflammation and scarring tend to be more prominent in the
portal tracts and periportal regions
- Mononuclear infiltrates rather than neutrophilic infiltrates
predominate
Robbins and Cotran Pathologic Basis of Disease
Robbins and Cotran Pathologic Basis of Disease
Robbins and Cotran Pathologic Basis of Disease
- Mitochondrial injury leading to diffuse, hepatocellular
microvesicular steatosis
- Associated with severe and potentially fatal acute liver
dysfunction
- Reye syndrome
- <4 age
- viral illness
- Pernicious vomiting, irritability or lethargy and hepatomegaly
- Serum bilirubin, ammonia, and aminotransferase levels are
essentially normal at presentation
- 25% progress to coma, accompanied by elevations in the serum
levels of bilirubin, aminotransferases, and particularly ammonia
- Death occurs from progressive neurologic deterioration or liver
failure
- Reye syndrome has been associated with aspirin administration
- No definitive evidence that salicylates play a causal role in this
disorder
- Aspirin is contraindicated in children and teenagers with febrile
illnesses
- Similar mitochondrial dysfunction caused by
- Tetracycline and valproate
- Toxins in unripe ackee fruit, popular in Jamaica
- Highly active antiretroviral therapy (HAART) regimens for HIV
- same histologic injuries
- but, spared significant morbidity
- Hepatocellular microvesicular steatosis
- Electron microscopy of hepatocellular mitochondria
- pleomorphic enlargement and electron lucency of the matrices
- disruption of cristae and loss of dense bodies
- Cerebral edema
- Astrocytes are swollen
- mitochondrial changes similar to those seen in the liver
- Inflammation is notably absent
- Skeletal muscles, kidneys, and heart also may reveal microvesicular
fatty change and mitochondrial alterations
Hemochromatosis
- Excessive accumulation of body iron
- Deposited in the liver, pancreas, and heart
- Most common form is an autosomal recessive disease of adult onset
- mutations in the HFE gene
- Secondary iron overload
- multiple transfusions, ineffective erythropoiesis (as in
β-thalassemia and myelodysplastic syndromes), and increased iron
intake
Hereditary Hemochromatosis
- Iron accumulates over the lifetime of the affected person
- Excessive intestinal absorption
- Total iron accumulation may exceed 50 gm, over one third of which is
found in the liver
- Fully developed cases
- cirrhosis (seen in all patients)
- diabetes mellitus (in 75% to 80% of patients)
- skin pigmentation (in 75% to 80%)
HFE gene
Located on the short arm of chromosome 6
Encodes a protein that is similar in structure to MHC class I
proteins
Expression of the mutated HFE protein on small intestinal enterocytes
leads to inappropriately upregulated absorption of iron and its binding
to transferrin
HFE and the other genes involved in less common forms of hereditary
hemochromatosis all regulate the levels of hepcidin, the iron hormone
produced by the liver
Hepcidin normally down-regulates the efflux of iron from the
intestines and macrophages into the plasma and inhibits iron
absorption
When hepcidin levels are reduced there is increased iron absorption
Excessive iron directly toxic to tissues
Lipid peroxidation by iron-catalyzed free radical reactions
Stimulation of collagen formation
Direct interactions of iron with DNA
Hemochromatosis
- Deposition of hemosiderin
- Liver, pancreas, myocardium, pituitary, adrenal, thyroid and
parathyroid glands, joints, skin, testis
- Liver
- Golden-yellow hemosiderin granules in the cytoplasm of periportal
hepatocytes, which stain blue with the Prussian blue stain
- Progressive involvement of the rest of the lobule
- Bile duct epithelium
- Kupffer cells
**Accumulation of iron results in a rusty brown liver **
Autopsy Pathology: A Manual and Atlas
Robbins Basic Pathology
Iron is a direct hepatotoxin, and inflammation is characteristically
absent
Liver typically is slightly larger than normal, dense, and chocolate
brown
Fibrous septa develop slowly
Cirrhosis in an intensely pigmented (very dark brown to black) liver
Dry weight:
Normal iron content of unfixed liver tissue <1000 µg/g dry weight
Clinically evident iron overload of hereditary hemochromatosis exhibit
>10,000 µg/g dry weight of iron
>22,000 µg/g dry weight are associated with the development of
fibrosis and cirrhosis
Wilson Disease
Autosomal recessive
Accumulation of toxic levels of copper
Liver, brain, and eye
Loss-of-function mutations in the ATP7B gene
Chromosome 13, encodes an ATPase metal ion transporter that localizes
to the Golgi region of hepatocytes
Normal copper physiology
Absorption of ingested copper (2 to 5 mg/day)
Plasma transport in complex with albumin
Hepatocellular uptake, followed by binding to an α2 -globulin
(apoceruloplasmin) to form ceruloplasmin
Secretion of ceruloplasmin-bound copper into plasma, where it accounts
for 90% to 95% of plasma copper
Hepatic uptake of desialylated, senescent ceruloplasmin from the
plasma, followed by lysosomal degradation and secretion of free copper
into bile
-
without ATP7B activity
- copper cannot be passed on to apoceruloplasmin and cannot be
excreted into bile
-
Copper accumulates progressively in hepatocytes
-
Toxic injury by
-
promoting the formation of free radicals
-
binding to sulfhydryl groups of cellular proteins
-
displacing other metals in hepatic metalloenzymes
-
By the age of 5 years
- Copper begins to escape from the overloaded, damaged hepatocytes
into the circulation
- Free copper generates oxidants Red cell hemolysis
- Deposited and damage to
- Brain, cornea, kidneys, bones, joints, and parathyroid glands
- Urinary excretion of copper increases markedly
-
Hepatocellular carcinoma is quite uncommon in Wilson disease
-
Kayser-Fleischer rings
- May mimic other liver diseases
- Fatty liver diseases
- Viral hepatitis
- Acute and chronic hepatitis
- Excess copper deposition can often be demonstrated by special
stains
- rhodanine stain for copper, orcein stain for copper-associated
protein
- Hepatic copper content in excess of 250 µg/g dry weight is most
helpful for making a diagnosis
- Basal ganglia, putamen
- Atrophy and even cavitation
- Hepatolenticular degeneration
- Kayser-Fleischer rings
- Green to brown deposits of copper in Descemet membrane in the
limbus of the cornea
α1-Antitrypsin Deficiency
Autosomal recessive disorder
Abnormally low serum levels
The major function of AAT is the inhibition of proteases
Pulmonary emphysema
Hepatic disease results from retention of mutant AAT in the liver
AAT synthesized predominantly by hepatocytes
Most allelic variants produce normal or mildly reduced levels of serum
AAT
Homozygotes for the Z allele ( PiZZ genotype) have circulating AAT
levels that are only 10% of normal levels
PiMZ heterozygotes have intermediate plasma levels of AAT
The PiZ polypeptide contains a single amino acid substitution that
results in misfolding of the nascent polypeptide in the hepatocyte
endoplasmic reticulum
Mutant protein cannot be secreted by the hepatocyte, it accumulates in
the endoplasmic reticulum and triggers unfolded protein response, lead
to induction of apoptosis
Marked cholestasis with hepatocyte necrosis in newborns
Childhood cirrhosis
Chronic hepatitis or cirrhosis that becomes apparent only late in
life
Hepatocellular carcinoma develops in 2% to 3% of adults with PiZZ
genotype, usually but not always in the setting of cirrhosis
The treatment and cure for the severe hepatic disease are orthotopic
liver transplantation
α1-Antitrypsin deficiency
Round to oval cytoplasmic globules composed of retained AAT
Glycoprotein stains with PAS
Robbins Basic Pathology